Copyright
©The Author(s) 2024.
World J Clin Cases. Jun 16, 2024; 12(17): 2995-3003
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2995
Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2995
Variable | OR (95%CI) | P value |
Age | ||
< 60 | 1.00 | 0.34 |
≥ 60 | 1.95 (0.49-7.81) | |
Laterality | ||
Left | 1.00 | |
Right | 1.34 (0.37-4.95) | 0.66 |
Surgery | ||
Lumpectomy | 1.00 | |
Mastectomy | 0.39 (0.10-1.49) | 0.17 |
Histologic type | ||
Ductal invasive carcinoma | 1.00 | |
Others | 0.00 (0.00-) | 1.0 |
Stage | ||
Ⅱ | 1.00 | |
Ⅲ | 0.34 (0.04-2.94) | 0.33 |
Anti-HER2 targeted therapy | ||
Yes | 1.00 | |
No | 1.05 (0.25-4.51) | 0.95 |
Chemotherapy | ||
Yes | 1.00 | |
No | 0.00(0.00- ) | 1.0 |
- Citation: Ji MC, Li ZJ, Li K, Wang YX, Yang B, Lv LL, Su Y, Zhang ZW, Huo ZC, Qi Q, Lu YC, Cui ZQ, Liu YB. Dosimetric risk factors for radiation esophagitis in patients with breast cancer following regional nodal radiation. World J Clin Cases 2024; 12(17): 2995-3003
- URL: https://www.wjgnet.com/2307-8960/full/v12/i17/2995.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i17.2995